Two Sigma Advisers’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $915K | Buy |
38,300
+300
| +0.8% | +$7.17K | ﹤0.01% | 1485 |
|
|
2025
Q1 | $944K | Sell |
38,000
-4,300
| -10% | -$107K | ﹤0.01% | 1496 |
|
|
2024
Q4 | $797K | Buy |
+42,300
| New | +$797K | ﹤0.01% | 1565 |
|
|
2024
Q3 | – | Sell |
-27,700
| Closed | -$792K | – | 2463 |
|
|
2024
Q2 | $792K | Sell |
27,700
-63,500
| -70% | -$1.82M | ﹤0.01% | 1672 |
|
|
2024
Q1 | $2.66M | Buy |
91,200
+9,500
| +12% | +$278K | 0.01% | 1072 |
|
|
2023
Q4 | $2.76M | Sell |
81,700
-36,000
| -31% | -$1.21M | 0.01% | 1107 |
|
|
2023
Q3 | $3.61M | Buy |
117,700
+44,100
| +60% | +$1.35M | 0.01% | 896 |
|
|
2023
Q2 | $2.95M | Buy |
73,600
+60,700
| +471% | +$2.43M | 0.01% | 1001 |
|
|
2023
Q1 | $526K | Buy |
+12,900
| New | +$526K | ﹤0.01% | 1928 |
|
|
2022
Q2 | – | Sell |
-16,776
| Closed | -$1.28M | – | 2828 |
|
|
2022
Q1 | $1.28M | Sell |
16,776
-61,200
| -78% | -$4.67M | ﹤0.01% | 1497 |
|
|
2021
Q4 | $4.69M | Sell |
77,976
-127,700
| -62% | -$7.68M | 0.01% | 797 |
|
|
2021
Q3 | $11.5M | Sell |
205,676
-151,600
| -42% | -$8.49M | 0.03% | 473 |
|
|
2021
Q2 | $21.7M | Buy |
357,276
+303,700
| +567% | +$18.4M | 0.06% | 312 |
|
|
2021
Q1 | $3.76M | Buy |
53,576
+26,800
| +100% | +$1.88M | 0.01% | 979 |
|
|
2020
Q4 | $1.6M | Buy |
26,776
+2,100
| +9% | +$126K | ﹤0.01% | 1369 |
|
|
2020
Q3 | $1.48M | Buy |
+24,676
| New | +$1.48M | ﹤0.01% | 1314 |
|
|
2020
Q2 | – | Sell |
-8,276
| Closed | -$277K | – | 2582 |
|
|
2020
Q1 | $277K | Sell |
8,276
-47,800
| -85% | -$1.6M | ﹤0.01% | 2045 |
|
|
2019
Q4 | $2.54M | Sell |
56,076
-6,400
| -10% | -$290K | 0.01% | 1116 |
|
|
2019
Q3 | $2.38M | Sell |
62,476
-223,500
| -78% | -$8.51M | 0.01% | 1047 |
|
|
2019
Q2 | $12.4M | Buy |
285,976
+46,200
| +19% | +$2.01M | 0.03% | 530 |
|
|
2019
Q1 | $9.13M | Sell |
239,776
-30,600
| -11% | -$1.16M | 0.02% | 637 |
|
|
2018
Q4 | $11.6M | Buy |
270,376
+117,500
| +77% | +$5.06M | 0.03% | 520 |
|
|
2018
Q3 | $7.51M | Buy |
+152,876
| New | +$7.51M | 0.02% | 668 |
|
|
2018
Q1 | – | Sell |
-221,076
| Closed | -$10.1M | – | 2392 |
|
|
2017
Q4 | $10.1M | Buy |
221,076
+199,376
| +919% | +$9.1M | 0.03% | 605 |
|
|
2017
Q3 | $815K | Sell |
21,700
-30,476
| -58% | -$1.14M | ﹤0.01% | 1554 |
|
|
2017
Q2 | $2.49M | Buy |
52,176
+37,800
| +263% | +$1.8M | 0.01% | 1095 |
|
|
2017
Q1 | $656K | Sell |
14,376
-5,024
| -26% | -$229K | ﹤0.01% | 1775 |
|
|
2016
Q4 | $627K | Buy |
19,400
+5,500
| +40% | +$178K | ﹤0.01% | 1754 |
|
|
2016
Q3 | $476K | Buy |
13,900
+7,800
| +128% | +$267K | ﹤0.01% | 1705 |
|
|
2016
Q2 | $206K | Buy |
+6,100
| New | +$206K | ﹤0.01% | 1852 |
|
|
2016
Q1 | – | Sell |
-4,300
| Closed | -$330K | – | 2110 |
|
|
2015
Q4 | $330K | Buy |
+4,300
| New | +$330K | ﹤0.01% | 1487 |
|
|
2014
Q4 | – | Sell |
-69,176
| Closed | -$6.71M | – | 2213 |
|
|
2014
Q3 | $6.71M | Buy |
69,176
+47,400
| +218% | +$4.59M | 0.05% | 380 |
|
|
2014
Q2 | $2M | Buy |
21,776
+17,200
| +376% | +$1.58M | 0.02% | 722 |
|
|
2014
Q1 | $320K | Buy |
+4,576
| New | +$320K | ﹤0.01% | 1408 |
|